Altered expression of histamine signaling genes in autism spectrum disorder

Translational Psychiatry

Volumn 7, Issue 5, 2017, Pages

  Wright, C ^a,b   Shin, J H ^a   Rajpurohit, A ^a   Deep Soboslay, A ^a   Collado Torres, L ^a   Brandon, N J ^b   Hyde, T M ^a   Kleinman, J E ^a   Jaffe, A E ^a,c,d   Cross, A J ^b   Weinberger, D R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASTRAZENECA   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; HISTAMINE METHYLTRANSFERASE; HISTIDINE DECARBOXYLASE; SMALL NUCLEOLAR RNA; HISTAMINE; HISTAMINE RECEPTOR; TRANSCRIPTOME;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTISM; CHILD; CONTROLLED STUDY; DORSOLATERAL PREFRONTAL CORTEX; FEMALE; GENE EXPRESSION; GENE REPLICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MOLECULAR PATHOLOGY; RNA SEQUENCE; COGNITION; DIAGNOSIS; DRUG EFFECTS; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GILLES DE LA TOURETTE SYNDROME; META ANALYSIS; METABOLISM; MIDDLE AGED; NEUROGENIC INFLAMMATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREFRONTAL CORTEX; PRESCHOOL CHILD; PROCEDURES; SEQUENCE ANALYSIS; SLEEP; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AUTISM SPECTRUM DISORDER; CHILD; CHILD, PRESCHOOL; COGNITION; DIAGNOSIS; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HISTAMINE; HUMANS; MALE; MIDDLE AGED; NEUROGENIC INFLAMMATION; PREFRONTAL CORTEX; RECEPTORS, HISTAMINE; SEQUENCE ANALYSIS, RNA; SLEEP; TOURETTE SYNDROME; TRANSCRIPTOME; YOUNG ADULT;

EID: 85038836470     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2017.87     Document Type: Article

References (68)

1. Brentani H, Paula CS, de, Bordini D, Rolim D, Sato F, Portolese J et al. Autism spectrum disorders: An overview on diagnosis and treatment. Rev Bras Psiquiatr 2013; 35: S62-S72.
2. Yoo H. Genetics of autism spectrum disorder: Current status and possible clinical applications. Exp Neurobiol 2015; 24: 257.
3. Buehler MR. A proposed mechanism for autism: An aberrant neuroimmune response manifested as a psychiatric disorder. Med Hypotheses 2011; 76: 863-870.
4. De Rubeis S, Buxbaum JD. Genetics and genomics of autism spectrum disorder: Embracing complexity. Hum Mol Genet 2015; 24: R24-R31.
5. Billstedt E, Gillberg C. Autism and Asperger syndrome: Coexistence with other clinical disorders. Acta Psychiatr Scand 2000; 102: 321-330.
6. Clarke RA, Lee S, Eapen V. Pathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism. Transl Psychiatry 2012; 2: E158.
7. Fernandez TV, Sanders SJ, Yurkiewicz IR, Ercan-Sencicek AG, Kim Y-S, Fishman DO et al. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biol Psychiatry 2012; 71: 392-402.
8. Muller N. Tourette's syndrome: Clinical features, pathophysiology, and therapeutic approaches. Dialogues Clin Neurosci 2007; 9: 161.
9. Kern JK, Geier DA, Sykes LK, Geier MR. Relevance of neuroinflammation and encephalitis in autism. Front Cell Neurosci 2016; 9: 519.
10. Theoharides TC, Stewart JM, Panagiotidou S, Melamed I. Mast cells, brain inflammation and autism. Eur J Pharmacol 2015; 778: 96-102.
11. Frick L, Rapanelli M, Abbasi E, Ohtsu H, Pittenger C. Histamine regulation of microglia: Gene-environment interaction in the regulation of central nervous system inflammation. Brain Behav Immun 2016; 57: 326-337.
12. Walenski M, Mostofsky SH, Ullman MT. Inflectional morphology in highfunctioning autism: Evidence for speeded grammatical processing. Res Autism Spectr Disord 2014; 8: 1607-1621.
13. Prat CS, Stocco A, Neuhaus E, Kleinhans NM. Basal ganglia impairments in autism spectrum disorder are related to abnormal signal gating to prefrontal cortex. Neuropsychologia 2016; 91: 268-281.
14. Walenski M, Mostofsky SH, Ullman MT. Speeded processing of grammar and tool knowledge in Tourette's syndrome. Neuropsychologia 2007; 45: 2447-2460.
15. Rodriguez JI, Kern JK. Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol 2011; 7: 205-213.
16. Jutel M, Blaser K, Akdis CA. Histamine in allergic inflammation and immune modulation. Int Arch Allergy Immunol 2005; 137: 82-92.
17. Dong H, Zhang W, Zeng X, Hu G, Zhang H, He S et al. Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia. Mol Neurobiol 2014; 49: 1487-1500.
18. Rocha SM, Pires J, Esteves M, Graãa B, Bernardino L. Histamine: A new immunomodulatory player in the neuron-glia crosstalk. Front Cell Neurosci 2014; 8: 120.
19. Ferreira R, Santos T, Gonçalves J, Baltazar G, Ferreira L, Agasse F et al. Histamine modulates microglia function. J Neuroinflammation 2012; 9: 1.
20. Ercan-Sencicek AG, Stillman AA, Ghosh AK, Bilguvar K, O'Roak BJ, Mason CE et al. L-histidine decarboxylase and Tourette's syndrome. N Engl J Med 2010; 362: 1901-1908.
21. Castellan Baldan L, Williams KA, Gallezot J-D, Pogorelov V, Rapanelli M, Crowley M et al. Histidine decarboxylase deficiency causes Tourette syndrome: Parallel findings in humans and mice. Neuron 2014; 81: 77-90.
22. Bolam JP, Ellender TJ. Histamine and the striatum. Neuropharmacology 2015; 106: 74-84.
23. Karagiannidis I, Dehning S, Sandor P, Tarnok Z, Rizzo R, Wolanczyk T et al. Support of the histaminergic hypothesis in Tourette Syndrome: Association of the histamine decarboxylase gene in a large sample of families. J Med Genet 2013; 50: 760-764.
24. Griswold AJ, Ma D, Cukier HN, Nations LD, Schmidt MA, Chung R-H et al. Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways. Hum Mol Genet 2012; 21: 3513-3523.
25. Mulatinho MV, de Carvalho Serao CL, Scalco F, Hardekopf D, Pekova S, Mrasek K et al. Severe intellectual disability, omphalocele, hypospadia and high blood pressure associated to a deletion at 2q22.1q22.3: Case report. Mol Cytogenet 2012; 5: 1.
26. Witkin J, Nelson D. Selective histamine H3 receptor antagonists for treatment of cognitive deficiencies and other disorders of the central nervous system. Pharmacol Ther 2004; 103: 1-20.
27. Shan L, Bao A-M, Swaab DF. The human histaminergic system in neuropsychiatric disorders. Trends Neurosci 2015; 38: 167-177.
28. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev 2008; 88: 1183-1241.
29. Rocha SM, Saraiva T, Cristóvão AC, Ferreira R, Santos T, Esteves M et al. Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation. J Neuroinflammation 2016; 13: 137.
30. Katoh Y, Niimi M, Yamamoto Y, Kawamura T, Morimoto-Ishizuka T, Sawada M et al. Histamine production by cultured microglial cells of the mouse. Neurosci Lett 2001; 305: 181-184.
31. Schwartz J-C, Arrang J-M, Garbarg M, Pollard H, Ruat M. Histamine transmission in the mammalian brain. Physiol Rev 1991; 71: 1-51.
32. Savage DD, Rosenberg MJ, Wolff CR, Akers KG, El-Emawy A, Staples MC et al. Effects of a novel cognition-enhancing agent on fetal ethanol-induced learning deficits. Alcohol Clin Exp Res 2010; 34: 1793-1802.
33. Kasteleijn-Nolst Trenité D, Parain D, Genton P, Masnou P, Schwartz J-C, Hirsch E. Efficacy of the histamine 3 receptor (H3R) antagonist pitolisant (formerly known as tiprolisant; BF2.649) in epilepsy: Dose-dependent effects in the human photosensitivity model. Epilepsy Behav 2013; 28: 66-70.
34. Baronio D, Gonchoroski T, Castro K, Zanatta G, Gottfried C, Riesgo R. Histaminergic system in brain disorders: Lessons from the translational approach and future perspectives. Ann Gen Psychiatry 2014; 13: 1-10.
35. Baronio D, Castro K, Gonchoroski T, de Melo GM, Nunes GDF, Bambini-Junior V et al. Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid. PLoS ONE 2015; 10: E0116363.
36. Linday L, Tsiouris J, Cohen I, Shindledecker R, DeCresce R. Famotidine treatment of children with autistic spectrum disorders: Pilot research using single subject research design. J Neural Transm 2001; 108: 593-611.
37. Rossi PG, Posar A, Parmeggiani A. Niaprazine in the treatment of autistic disorder. J Child Neurol 1999; 14: 547-550.
38. Gonzalez-Gadea ML, Chennu S, Bekinschtein TA, Rattazzi A, Beraudi A, Trippichio P et al. Predictive coding in autism spectrum disorder and attention deficit hyperactivity disorder. J Neurophysiol 2015; 114: 2625-2636.
39. Stevenson J, Sonuga-Barke E, McCann D, Grimshaw K, Parker KM, Rose-Zerilli MJ et al. The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children's ADHD symptoms. Am J Psychiatry 2010; 167: 1108-1115.
40. Lipska BK, Deep-Soboslay A, Weickert CS, Hyde TM, Martin CE, Herman MM et al. Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia. Biol Psychiatry 2006; 60: 650-658.
41. Trapnell C, Pachter L, Salzberg SL. TopHat: Discovering splice junctions with RNA-Seq. Bioinformatics 2009; 25 (9): 1105-1111.
42. Liao Y, Smyth GK, Shi W. featureCounts:an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014; 30 (7): 923-930.
43. Buja A, Eyuboglu N. Remarks on parallel analysis. Multivar Behav Res 1992; 27: 509-540.
44. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. sva: Surrogate Variable Analysis. R Package Version 3.8.0 2013. https://bioconductor.org/packages/release/ bioc/html/sva.html.
45. Smyth GK. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: 1-25.
46. Smyth GK. Limma: Linear models for microarray data.Gentleman R, Carey V, Dudoit S, Irizarray R, Huber W(Eds.), Bioinformatics and Computational Biology Solutions using R and Bioconductor. Springer: New York, 2005; 397-420.
47. Lai M-C, Lombardo MV, Auyeung B, Chakrabarti B, Baron-Cohen S. Sex/gender differences and autism: Setting the scene for future research. J Am Acad Child Adolesc Psychiatry 2015; 54: 11-24.
48. Wu D, Lim E, Vaillant F, Asselin-Labat M-L, Visvader JE, Smyth GK. ROAST: Rotation gene set tests for complex microarray experiments. Bioinformatics 2010; 26: 2176-2182.
49. Rahmatallah Y, Emmert-Streib F, Glazko G. Gene set analysis approaches for RNAseq data: Performance evaluation and application guideline. Brief Bioinform 2016; 17: 393-407.
50. Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG et al. The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford) 2016; 2016: Baw100.
51. Del Re AC. compute.es: Compute Effect Sizes. R Package 2013. http://cran.rproject. org/web/packages/compute.es.
52. Parikshak NN, Swarup V, Belgard TG, Irimia M, Ramaswami G, Gandal MJ et al. Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism. Nature 2016; 540: 423-427.
53. Dewey M. metap: Meta-analysis of significance values. R Package Version 0.8 2017. https://CRAN.R-project.org/package = metap.
54. Irimia M, Weatheritt RJ, Ellis JD, Parikshak NN, Gonatopoulos-Pournatzis T, Babor M et al. A highly conserved program of neuronal microexons is misregulated in autistic brains. Cell 2014; 159: 1511-1523.
55. Gupta S, Ellis SE, Ashar FN, Moes A, Bader JS, Zhan J et al. Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activitydependent genes in autism. Nat Commun 2014; 5: 5748.
56. Feinberg JI, Bakulski KM, Jaffe AE, Tryggvadottir R, Brown SC, Goldman LR et al. Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort. Int J Epidemiol 2015; 44: 1199-1210.
57. Tassano E, Mirabelli-Badenier M, Veneselli E, Puliti A, Lerone M, Vaccari CM et al. Clinical and molecular characterization of a patient with interstitial 6q21q22.1 deletion. Mol Cytogenet 2015; 8: 31.
58. Jaffe AE, Gao Y, Deep-Soboslay A, Tao R, Hyde TM, Weinberger DR et al. Mapping DNA methylation across development, genotype and schizophrenia in the human frontal cortex. Nat Neurosci 2016; 19: 40-47.
59. Ladd-Acosta C, Hansen KD, Briem E, Fallin MD, Kaufmann WE, Feinberg AP. Common DNA methylation alterations in multiple brain regions in autism. Mol Psychiatry 2014; 19: 862-871.
60. Rapanelli M, Pittenger C. Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions. Neuropharmacology 2015; 106: 85-90.
61. Chepkova A, Yanovsky E, Parmentier R, Ohtsu H, Haas HL, Lin J-S et al. Histamine receptor expression, hippocampal plasticity and ammonia in histidine decarboxylase knockout mice. Cell Mol Neurobiol 2012; 32: 17-25.
62. Lennington JB, Coppola G, Kataoka-Sasaki Y, Fernandez TV, Palejev D, Li Y et al. Transcriptome analysis of the human striatum in Tourette syndrome. Biol Psychiatry 2016; 79: 372-382.
63. Kotsopoulos S, Kutty KM. Histidinemia and infantile autism. J Autism Dev Disord 9: 55-60.
64. Naushad SM, Jain JM, Prasad CK, Naik U, Akella RR. Autistic children exhibit distinct plasma amino acid profile. Indian J Biochem Biophys 2013; 50: 474-478.
65. Bañuelos-Cabrera I, Valle-Dorado MG, Aldana BI, Orozco-Suárez SA, Rocha L. Role of histaminergic system in blood-brain barrier dysfunction associated with neurological disorders. Arch Med Res 2014; 45: 677-686.
66. Tsai C-S, Yang Y-H, Huang K-Y, Lee Y, McIntyre RS, Chen VC-H. Association of Tic disorders and enterovirus infection: A nationwide population-based study. Medicine (Baltimore) 2016; 95: E3347.
67. Theoharides TC, Tsilioni I, Patel AB, Doyle R. Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders. Transl Psychiatry 2016; 6: E844.
68. Chang Y-T, Li Y-F, Muo C-H, Chen S-C, Chin Z-N, Kuo H-T et al. Correlation of Tourette syndrome and allergic disease: nationwide population-based casecontrol study. J Dev Behav Pediatr 2011; 32: 98-102.